EU Warns Of Anaphylaxis With MS Drug ‘Months Or Years’ After Start Of Treatment

 
• By Ian Schofield
  
Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science to detection, monitoring, and prevention of adverse effects with pharmaceutical product
The EU has flagged up a new safety concern over glatiramer acetate • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography